Introduction
Aplastic anaemia is a rare but serious bone-marrow failure syndrome in which the marrow produces too few red blood cells, white blood cells, and platelets (pancytopenia). Without enough of these cells, people develop anaemia, infection risk, and bleeding tendency.
Many cases are acquired and thought to involve immune-mediated attack on haematopoietic stem cells. Others follow drugs, chemicals (such as benzene), radiation, or viruses. Inherited bone-marrow failure syndromes (including Fanconi anaemia) can present similarly and need specific testing, especially in younger patients.
Incidence is roughly a few cases per million people per year. Peaks occur in adolescents/young adults and again in older adults. Both sexes are affected. Severity is graded by blood-count thresholds into non-severe, severe, and very severe disease—guiding urgency of therapy.
Modern care—immunosuppression, supportive transfusions, infection management, and haematopoietic stem-cell transplantation—has improved survival. This page is general education; treatment choices are individual and specialist-led.
Overview
In aplastic anaemia the marrow is hypocellular: fat replaces blood-forming tissue, and peripheral counts fall across all lineages. It is distinct from leukaemia and myelodysplastic syndromes, where abnormal cells or dysplasia dominate.
Acute presentations can become life-threatening within days to weeks. Chronic or moderate forms may smoulder with fatigue and intermittent infections or bruising.
Goals of care are to prevent infection and bleeding, restore marrow function when possible, and offer curative transplant to appropriate candidates.
- Marrow failure → low red cells, white cells, and platelets
- Immune, toxic, viral, idiopathic, or inherited causes
- Classified by severity (non-severe / severe / very severe)
- Must be distinguished from MDS, leukaemia, and other cytopenias
- Diagnosis requires CBC plus bone-marrow examination
- Treatment: support, immunosuppression, and/or stem-cell transplant
What happens in the body
Haematopoietic stem cells in the marrow are damaged or suppressed—often by cytotoxic T-cell attack—so production of erythrocytes, leukocytes, and megakaryocytes collapses. Reticulocyte counts fall because few new red cells are made.
Low neutrophils allow bacterial and fungal invasion; low platelets impair clotting; low haemoglobin reduces oxygen delivery, causing fatigue, pallor, and cardiopulmonary strain. Without treatment, progressive marrow failure can be fatal.
- Stem-cell loss/suppression → empty marrow and pancytopenia
- Anaemia, neutropenia, and thrombocytopenia drive symptoms
- Immune injury is central in many acquired cases
- Inherited syndromes need separate genetic pathways of care
Signs and symptoms
Early signs can be subtle; advanced disease is more dramatic. Common patterns include:
- Persistent fatigue, weakness, and reduced stamina
- Pallor and shortness of breath on exertion
- Dizziness or light-headedness
- Frequent or severe infections and fever
- Easy bruising, gum or nose bleeding, heavy periods
- Petechiae (pinpoint skin bleeds)
- Rapid heartbeat as the body compensates for anaemia
- Mild: slight fatigue or incidental cytopenias
- Moderate: clear anaemia symptoms, infections, and bruising
- Severe: life-threatening infection or haemorrhage
- Children: infections, bruising, fatigue, sometimes growth concerns
- Less common: headache, joint pains, or rashes needing differential review
Causes and risk factors
After excluding look-alike marrow diseases, causes and risk factors often discussed include:
- Idiopathic acquired aplastic anaemia (no cause identified)
- Autoimmune attack on marrow stem cells
- Drugs and toxins (including benzene and selected medicines)
- Ionising radiation exposure
- Viral associations (for example hepatitis-associated, EBV, HIV, and others in context)
- Inherited bone-marrow failure (Fanconi anaemia and related syndromes)
- Overlap or evolution concerns with PNH and MDS (specialist testing)
- Age peaks in young adults and older adults
- Family history of marrow failure prompting genetic evaluation
Diagnosis and evaluation
Accurate diagnosis is essential before immunosuppression or transplant:
- History of cytopenia symptoms, exposures, hepatitis, family marrow disease, and medicines
- Exam for pallor, petechiae, infection, and absence of major lymphadenopathy or organomegaly (which may suggest other diseases)
- CBC showing pancytopenia; low reticulocyte count
- Bone-marrow aspirate and biopsy confirming hypocellular marrow without leukaemic infiltration
- Flow cytometry / PNH testing and cytogenetics or NGS panels as indicated
- Inherited marrow-failure work-up in younger patients or suggestive features
- Imaging only as needed to exclude alternative diagnoses
- Differentiate from MDS, aleukaemic leukaemia, hypocellular marrow mimics, and nutritional cytopenias
Treatment and management
Therapy intensity follows severity, age, donor availability, and comorbidities. Do not start immunosuppressants without specialist confirmation of the diagnosis:
- Supportive care: red-cell and platelet transfusions; infection prophylaxis and urgent fever management
- Iron chelation when cumulative transfusions cause iron overload
- Immunosuppressive therapy (for example ATG-based regimens with ciclosporin) for severe disease without an immediate matched sibling transplant option
- Haematopoietic stem-cell transplantation as potentially curative therapy in suitable patients, especially younger people with a matched donor
- Growth factors (such as G-CSF) as adjuncts in selected settings—not a standalone cure
- Androgens (for example danazol) in selected refractory or special populations under specialist advice
- Avoid live vaccines and high-risk exposures while neutropenic unless cleared by the team
- Clinical-trial options in refractory disease at experienced centres
- Long-term surveillance for relapse, clonal evolution, and treatment late effects
Prevention, self-care, and lifestyle
Not every condition is fully preventable, but the steps below may lower risk or recurrence:
- No reliable primary prevention for idiopathic disease; reduce avoidable toxin and radiation exposures
- Use medicines only as prescribed; report unexpected bruising or fever on high-risk drugs promptly
- Vaccinate as recommended when counts and timing allow
- Genetic counselling and cascade testing when an inherited syndrome is found
- Regular blood-count monitoring after recovery or during immunosuppression taper
- Infection-avoidance behaviour during neutropenia (hygiene, food safety as advised)
Possible complications
Delay, missed care, or unsafe self-medication can raise the chance of complications in some cases:
- Septic shock and invasive fungal infection
- Major haemorrhage (including intracranial or gastrointestinal)
- Transfusion iron overload and alloimmunisation
- Relapse after immunosuppression
- Clonal evolution to MDS or leukaemia in a subset of patients
- Transplant-related complications (graft-versus-host disease, infection) when transplant is used
- Chronic fatigue and reduced quality of life during prolonged cytopenias
When to see a doctor or seek emergency care
Seek prompt medical advice or emergency care if any of the following apply—it is safer not to wait and see:
- Fever if you have known or suspected low neutrophils—emergency pathway
- Uncontrolled bleeding, black stools, vomiting blood, or severe headache with cytopenias
- Rapidly worsening shortness of breath, chest pain, fainting, or confusion
- New widespread petechiae or expanding bruises
- Persistent fatigue with recurrent infections or easy bleeding—prompt haematology referral
Living with the condition
Build a daily routine around rest, planned activity, and infection precautions; keep an updated medication and transfusion record.
Discuss work, school, travel, and dental procedures with the haematology team before they happen.
Use counselling or peer support if anxiety or depression develops during long treatment courses; caregivers need clear fever and bleeding action plans.
Frequently asked questions
What is aplastic anaemia?
A bone-marrow failure condition with too few red cells, white cells, and platelets because the marrow cannot produce them adequately.
Is it life-threatening?
It can be, mainly from infection and bleeding. Urgent specialist care greatly improves outcomes.
Is it curable?
Stem-cell transplant can cure many eligible patients. Others achieve durable remissions with immunosuppression plus supportive care.
Is it cancer?
No—it is marrow failure, not a cancer of white cells. Still, doctors carefully exclude leukaemia and MDS because treatments differ.
Can it be genetic?
Some cases are inherited marrow-failure syndromes. Many are acquired. Family history and age guide genetic testing.
Can it come back after treatment?
Yes. Relapse can occur, especially around immunosuppression taper. Lifelong follow-up of blood counts is important.
Important caution
This article is general health education in English. It is not personal medical advice, a prescription, or a substitute for clinical assessment.
Immunosuppression and transplant decisions require an experienced haematology team and informed consent about benefits and risks.
If fever in neutropenia, heavy bleeding, or sudden collapse occurs, seek emergency care immediately.